Jeff Wolf

Managing Partner

Jeff has 20 years experience in creating, running and growing new ventures based upon breakthrough research and technology. Jeff was formerly managing director at The Castle Group, a New York based venture firm. Jeff founded Seed-One in 1997 to focus on identifying and acquiring cutting-edge technologies and systematically forming and running early-stage, high-growth companies based on these breakthroughs.

Since founding Seed-One, Jeff has created and ran over a dozen high-growth biomedical companies companies including Avigen, a San Francisco-based gene therapy company; TyRx, a Princeton-based firm focused on the development of bio-compatible polymers; EluSys Therapeutics, a New Jersey company focused on the development of a novel technology to remove blood-borne pathogens; Sensatex, a Maryland company focused on the development of novel medical diagnostic systems; GenerationOne, a Miami-based company focused on mobile-based collaborative care; and Heat Biologics, a company focused on the development of novel therapeutics to prime the immune system against a variety of disorders.

Jeff received his M.B.A. from Stanford Business School, his J.D. from New York University School of Law and his B.A. from the University of Chicago, where he graduated with honors in Economics.

Scott Wolf, M.D.

Managing Partner

Scott is a prolific medical device entrepreneur, inventor and venture capitalist. Over the past 20 years, Scott founded numerous successful medical device companies across a broad range of therapeutic areas.

Scott was a partner with Prospect Venture Partners and Frazier Healthcare Ventures, both leading life science venture capital firm.

Scott founded and served as CEO of Zeltiq, which markets the first effective non-invasive method of bodysculpting and cellulite therapy, and Primaeva, acquired by Syneron Medical (ELOS), which developed and is marketing a device for office based aesthetic procedures. Zeltiq recently filed for an initial public offering. Scott’s latest start-up is Aerin Medical, a company he formed to commercialize his newly invented device and procedure to improve nasal breathing. Scott was also a founder Cardiac Dimensions and Endogastric Solutions, two successful medical device companies.

Scott’s companies are funded by the leading life science corporations and venture capital firms, including Venrock, ATV, Interwest, Johnson & Johnson Development Corporation, Medtronic, Mitsubishi UFJ Capital, MPM and Frazier Healthcare Ventures.

Scott received his M.D. from George Washington University and his B.A. from the University of Pennsylvania.

Paul Belsky, M.D.

Clinical Advisor

Paul is focused on seeking and acquiring new technologies for the formation of cutting edge biomedical companies. Dr. Belsky has extensive expertise in the clinical practice of internal medicine and cardiovascular diseases and was formerly on the clinical academic faculty at Weill College of Medicine, Cornell University. He is a fellow of the American College of Cardiology, the American College of Chest Physicians, a member of the American College of Physicians and a Clinical Assistant Professor of Medicine at New York University School of Medicine. Dr. Belsky served as a scientific advisor to Elusys Therapeutics, Sensatex, and TyrxPharma.

Paul received his M.D. from the University of California at San Francisco, and his AB in Biology from Brown University where he was elected Phi Beta Kappa.

Lisa Maier, Ph.D.

Vice President

Lisa completed her graduate work focusing on the genetic basis of autoimmune disease at the Cambridge Institute for Medical Research, University of Cambridge (UK), having been awarded a highly competitive Wellcome Trust Prize Studentship. The Juvenile Diabetes Research Foundation awarded Lisa a postdoctoral fellowship to study the immunological effects of genetic risk variants associated with autoimmunity at the Center for Neurologic Disease, Harvard Medical School, where she is now junior faculty. Lisa is also an affiliate of the Broad Institute of M.I.T. and Harvard University. She has authored numerous publications that span several scientific disciplines in top-tier journals including Nature, Nature Genetics and PNAS.

Lisa received her B.Sc. in Biomedical Science from Anglia Ruskin University (UK) and her Ph.D. in Medical Genetics from the University of Cambridge, Gonville and Caius College (UK).

Omar Jabado, Ph.D.

Technology Analyst

Prior to joining Seed-One, Omar was also an analyst for Columbia University’s technology transfer office, evaluating the novelty, marketability and commercialization path for hundreds of inventions. Omar’s academic focus was in bioinformatics, creating algorithms that enabled discovery of new and emerging viruses. Omar earned his Ph.D. in Biology from Columbia University. Prior to the doctorate, he received a M.A. in Biotechnology from Columbia and a B.A. in Neuroscience from Cornell University. His graduate work was in public health, developing novel technologies to detect pathogens.